selected publications
-
abstract
- Jason Dubroff, Melendres L, High geographic prevalence of pulmonary artery hypertension: associations with ethnicity, drug use, and altitude. Pulmonary Circulation 2019
- Franck R, Melendres-Groves L, Abstract: The Motion Study to Assess the Effect of Riociguat on Patient-Reported Outcomes in PAH: Correlations Between the Living with Pulmonary Hypertension Questionnaire and Secondary Endpoints. Accepted Abstract and Poster, ATS 2018 2018
- Macitentan: OPsumit Users (OPUS) Registry. Accepted Abstract and Poster, ATS 2018 2018
- Sandeep S, Melendres-Groves, L, Pulmonary Hypertension Care Center Network Improving care and outcomes in PH. Chest 2017 Apr;151(4):749-754 2017
- Bhatia S, Melendres-Groves L. Pulmonary Hypertension in Chronic Myeloproliferative Disorders. Advances in Pulmonary Hypertension 2016 2016
- Terpenning S, Melendres-Groves L, Abstract: MRI Assessment of Candidates for Vasodilator Treatment of Pulmonary Arterial Hypertension (PAH): Reproducibility and Accuracy, Presented at Radiology Society of North America 2016 Annual Conference 2016
-
academic article
-
case study
- Balasubramanian V, Melendres-Groves L, Real-World Dosing Characteristics of Parenteral Treprostinil. Accepted Abstract for Thematic Poster Session, CHEST 2019 2019
- Kakol M, Melendres-Groves L, Pulmonary Hypertension and the Fertile Female - Optimizing Contraceptive Protocols at an Accredited Center for Comprehensive Pulmonary Hypertension Care, Accepted Abstract ATS 2019 2019
- Kim N, Melendres-Groves L, Macitentan in pulmonary hypertension (PH): Data from OPUS and OrPHeUS real world datasets. Abstract ERS 2019 2019
- Leary PJ, Lahm T, Melendres-Groves L, Which Needle in Which Haystack? Multisystem Care for Pulmonary Hypertension Patients. Ann Am Thorac Soc 2019
- Melendres-Groves L, Ask the Expert: What is the exercise “prescription” that you provide to your patients? Advnaces in PH: 2019, Vol 18 2019
- Balasubramanian V, Melendres-Groves L, Real-World Experience with riociguat as potential bridging therapy in patients with chronic thromboembolic pulmonary hypertension: a case series. Pending publication in Pulmonary Circulation 2018
- Channick R, Melendres-Groves L, Abstract: Patient Characteristics and Treatment Patterns in the Largest Real-World Cohort of PAH Patients Newly Treated with 2018
- Kim N, Melendres-Groves L, Macitentan in pulmonary hypertension (PH): Data from OPUS and OrPHeUS real world datasets. Abstract ERS 2019 2018
- McLaughlin V, Melendres-Groves L, Real-world treatment with macitentan: Data from the OPsumit® USers Registry (OPUS) and the OPsumit® Historical Users cohort (OrPHeUS), 2018
- Medrek SK, Melendres-Groves L, Untangling BNP and BMI: Does Obesity Limit the Predictive Capability of BNP in PAH? Chest 2018 Nov 2018